Mike Matson Stock Analyst Profile - Needham Research Coverage - Stocknear

Mike Matson

Stock Analyst at Needham

(4.19)
# 1884
Out of 5,506 analysts
635
Total ratings
Success rate
Average return

44 Stocks

Name Action PT Current % Upside Ratings Updated
BSX Boston Scientific
Reiterates: Buy
121 121
97.31 24.34% 33 Oct 1, 2025
LIVN LivaNova
Reiterates: Buy
64 64
53.37 19.92% 27 Sep 3, 2025
NEO NeoGenomics
Maintains: Strong Buy
8 14
9.1 53.85% 27 Aug 29, 2025
TMDX TransMedics Group
Reiterates: Hold
n/a
n/a n/a 12 Aug 25, 2025
AORT Artivion
Maintains: Strong Buy
45 50
41.08 21.71% 19 Aug 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
3.35 26.87% 1 Aug 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 20 Aug 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
1.04 188.46% 21 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
57 49
32.07 52.79% 16 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
84 68
50.48 34.71% 14 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
442 448
370.6 20.89% 9 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 20 Jul 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
44 45
34.81 29.27% 35 Jul 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
108 108
84.21 28.25% 30 Jul 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
48 48
41.43 15.86% 3 Jun 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
61 61
48.13 26.74% 25 Jun 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 21 May 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
12
8.65 38.73% 19 May 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
n/a n/a 18 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
42 42
18.77 123.76% 23 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
51 41
36 13.89% 17 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 21 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 25 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
7.34 -4.63% 20 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 5 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 11 Apr 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 9 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 10 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 26 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 14 Jan 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
13 13
n/a n/a 16 Jan 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 21 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 9 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 7 Apr 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 5 Nov 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 8
n/a n/a 1 Sep 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
38 39
n/a n/a 8 Jul 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
34 42
14.5 189.66% 2 May 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 5 Mar 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
65 75
60.48 24.01% 1 Feb 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Jan 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Nov 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
74
n/a n/a 1 Jun 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Mar 13, 2020